Ocular Therapeutix plans an initial public offering worth up to $80 million.
Ocular Therapeutix is looking to raise as much as $80 million in a forthcoming initial public offering, the company said today.
Bedford, Mass.-based Ocular Therapeutix said it plans to offer 5 million shares at $14 to $16 apiece, making the IPO worth $70 million to $80 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nevBFZ
Cap comentari:
Publica un comentari a l'entrada